Leukemia Research
Volume 24, Issue 12 , Pages 1049-1057 , December 2000

PMA-treated K-562 leukemia cells mediate a TH2-specific expansion of CD4+ T cells in vitro

  • Erich J Baker

      Affiliations

    • Department of Medical Biology, Graduate School of Medicine, University of Tennessee Medical Center at Knoxville, 1924 Alcoa Highway, Knoxville, TN 37920, USA
    • ,
  • Albert T Ichiki

      Affiliations

    • Department of Medical Biology, Graduate School of Medicine, University of Tennessee Medical Center at Knoxville, 1924 Alcoa Highway, Knoxville, TN 37920, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-865-5449467; fax: +1-865-5449460
    • ,
  • James W Hodge

      Affiliations

    • National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
    • ,
  • Devadas Sugantharaj

      Affiliations

    • Department of Medical Biology, Graduate School of Medicine, University of Tennessee Medical Center at Knoxville, 1924 Alcoa Highway, Knoxville, TN 37920, USA
    • ,
  • Elena G Bamberger

      Affiliations

    • Department of Medical Biology, Graduate School of Medicine, University of Tennessee Medical Center at Knoxville, 1924 Alcoa Highway, Knoxville, TN 37920, USA
    • ,
  • Carmen B Lozzio

      Affiliations

    • Department of Medical Biology, Graduate School of Medicine, University of Tennessee Medical Center at Knoxville, 1924 Alcoa Highway, Knoxville, TN 37920, USA

Received 17 February 2000 ,Accepted 16 June 2000.

References 

  1. Van Seventer GA, Shimizu Y, Horgan KJ, Shaw S. The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells. J. Immunol. 1990;144:4579–4586
  2. Van Lier RA, Pool MO, Kabel P, et al.  Anti-CD27 monoclonal antibodies identify two functionally distinct subpopulations within the CD4+ T cell subset. Eur. J. Immunol. 1988;18:811–816
  3. Linsley PS, Brady W, Grosmaire L, Aruffo A, Damle NK, Ledbetter JA. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J. Exp. Med. 1991;173:721–730
  4. Grewal IS, Flavell RA. The role of CD40 ligand in costimulation and T-cell activation. Immunol. Rev. 1996;153:85–106
  5. Makgoba MW, Sanders ME, Shaw S. The CD2-LFA-3 and LFA-1-ICAM pathways: relevance to T-cell recognition. Immunol. Today. 1989;10:417–422
  6. Weaver CT, Hawrylowicz CM, Unanue ER. T helper cell subsets require the expression of distinct costimulatory signals by antigen-presenting cells. Proc. Natl. Acad. Sci. USA. 1988;85:8181–8185
  7. Lichtman AH, Chin J, Schmidt JA, Abbas AK. Role of interleukin 1 in the activation of T lymphocytes. Proc. Natl. Acad. Sci. USA. 1988;85:9699–9703
  8. Palm N, Germann T, Goedert S, Hoehn P, Koelsch S, Rude E, et al. Co-development of naive CD4+ cells towards T helper type 1 or T helper type 2 cells induced by a combination of IL-12 and IL-4. Immunobiology. 1996;196:475–484
  9. Ayala A, Ertel W, Chaudry IH. Trauma-induced suppression of antigen presentation and expression of major histocompatibility class II antigen complex in leukocytes [editorial]. Shock. 1996;5:79–90
  10. Stein PH, Singer A. Similar co-stimulation requirements of CD4+ and CD8+ primary T helper cells: role of IL-1 and IL-6 in inducing IL-2 secretion and subsequent proliferation. Int. Immunol. 1992;4:327–335
  11. Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 1989;7:145–173
  12. Lucey DR, Clerici M, Shearer GM. Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. Clin. Microbiol. Rev. 1996;9:532–562
  13. Costello RT, Mallet F, Sainty D, Maraninchi D, Gastaut JA, Olive D. Regulation of CD80/B7-1 and CD86/B7-2 molecule expression in human primary acute myeloid leukemia and their role in allogenic immune recognition. Eur. J. Immunol. 1998;28:90–103
  14. Pawelec G, Rehbein A, Schlotz E, da Silva P. Cellular immune responses to autologous chronic myelogenous leukaemia cells in vitro. Cancer Immunol. Immunother. 1996;42:193–199
  15. Coleman S, Fisher J, Hoy T, Burnett AK, Lim SH. Autologous MHC-dependent leukaemia-reactive T lymphocytes in a patient with chronic myeloid leukaemia. Leukemia. 1996;10:483–487
  16. Sato M, Goto S, Kaneko R, Ito M, Sato S, Takeuchi S. Impaired production of Th1 cytokines and increased frequency of Th2 subsets in PBMC from advanced cancer patients. Anticancer Res. 1998;18:3951–3955
  17. Wakasugi H, Harel A, Dokhelar MC, Fradelizi D, Tursz T. Leukemia cell lines can replace monocytes for mitogen-induced T- lymphocyte responses: this accessory function is dependent upon their differentiation stage. Proc. Natl. Acad. Sci. USA. 1983;80:6028–6031
  18. Wakasugi H, Harel A, Dokhelar MC, Fradelizi D, Tursz T. Accessory function and interleukin 1 production by human leukemic cell lines. J. Immunol. 1984;132:2939–2947
  19. Drew SI, Terasaki PI, Billing RJ, Bergh OJ, Minowada J, Klein E. Group-specific human granulocyte antigens on a chronic myelogenous leukemia cell line with a Philadelphia chromosome marker. Blood. 1977;49:715–718
  20. Lozzio BB, Lozzio CB. Properties and usefulness of the original K-562 human myelogenous leukemia cell line. Leuk. Res. 1979;3:363–370
  21. Ichiki AT, Bamberger EG, Wust CJ, Lozzio CB. Diversity of cell surface hematopoietic antigens on K-562 sublines indentified with monoclonal antibodies. Leuk. Res. 1986;10:565–574
  22. Lozzio CB, Lozzio BB. Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood. 1975;45:321–334
  23. Ichiki AT, Langenberg M, Baker EJ, Hodge JW, Bamberger EG, Gerard DA, et al. Differential regulation of interleukin-1α and interleukin-1β in K-562 cells. J. Interferon Cytokine Res. 1998;18:1045–1050
  24. Colter M, Fogarty B, McGuire K, Berenson R, Heimfeld S. Rapid isolation of CD4 or CD8 T-cell subsets using the CEPRATE LC laboratory cell separation system. Transplant Proc. 1992;24:2801–2802
  25. Benoist H, Joly P, Broglio C, et al.  Studies on the susceptibility to NK-mediated lysis and the simultaneous expression of various surface molecules in anthracyclin-treated K562 cells and in four K562 cell clones. Immunol. Lett. 1992;34:45–56
  26. Tetteroo PA, Massaro F, Mulder A, Schreuder-van Gelder R, von dem Borne AE. Megakaryoblastic differentiation of proerythroblastic K562 cell-line cells. Leuk. Res. 1984;8:197–206
  27. Alitalo R. Induced differentiation of K562 leukemia cells: a model for studies of gene expression in early megakaryoblasts. Leuk. Res. 1990;14:501–514
  28. Hirano N, Takahashi T, Ohtake S, et al.  Expression of costimulatory molecules in human leukemias. Leukemia. 1996;10:1168–1176
  29. Houssiau FA, Coulie PG, Olive D, Snick JV. Synergistic activation of human T cells by interleukin 1 and interleukin 6. Eur. J. Immunol. 1988;18:653–656
  30. Yamamura M, Modlin RL, Ohmen JD, Moy RL. Local expression of antiinflammatory cytokines in cancer. J. Clin. Invest. 1993;91:1005–1010
  31. Seder RA, Paul WE. Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annu. Rev. Immunol. 1994;12:635–673
  32. Kobayashi M, Kobayashi H, Pollard RB, Suzuki F. A pathogenic role of Th2 cells and their cytokine products on the pulmonary metastasis of murine B16 melanoma. J. Immunol. 1998;160:5869–5873
  33. Constant S, Pfeiffer C, Woodard A, Pasqualini T, Bottomly K. Extent of T cell receptor ligation can determine the functional differentiation of naive CD4+ T cells. J. Exp. Med. 1995;182:1591–1596
  34. Van Gool SW, Vandenberghe P, de Boer M, Ceuppens JL. CD80, CD86 and CD40 provide accessory signals in a multiple-step T-cell activation model. Immunol. Rev. 1996;153:47–83
  35. Navarro S, Mitjavila MT, Katz A, Doly J, Vainchenker W. Expression of interleukin 6 and its specific receptor by untreated and PMA-stimulated human erythroid and megakaryocytic cell lines. Exp. Hematol. 1991;19:11–17
  36. Talley CJ, Turner EA, Hatcher FM, Aguinaga PM, Chakrabarti P. Tiazofurin-induced autosecretion of IL-6 and hemoglobin production in K562 human leukemia cells. Am. J. Hematol. 1997;54:301–305
  37. Dougherty GJ, Murdoch S, Hogg N. The function of human intercellular adhesion molecule-1 (ICAM-1) in the generation of an immune response. Eur. J. Immunol. 1988;18:35–39
  38. Umehara H, Huang JY, Kono T, et al.  Co-stimulation of T cells with CD2 augments TCR-CD3-mediated activation of protein tyrosine kinase p72syk, resulting in increased tyrosine phosphorylation of adapter proteins, Shc and Cbl [In Process Citation]. Int. Immunol. 1998;10:833–845
  39. van Noesel C, Miedema F, Brouwer M, de Rie MA, Aarden LA, van Lier RA. Regulatory properties of LFA-1 alpha and beta chains in human T- lymphocyte activation. Nature. 1988;333:850–852
  40. Pircher H, Groscurth P, Baumhutter S, Aguet M, Zinkernagel RM, Hengartner H. A monoclonal antibody against altered LFA-1 induces proliferation and lymphokine release of cloned T cells. Eur. J. Immunol. 1986;16:172–181
  41. Dimery IW, Ross DD, Testa JR, Gupta SK, Felsted RL, Pollak A, et al. Variation amongst K562 cell cultures. Exp. Hematol. 1983;11:601–610
  42. Fuhr JE, Bamberger EG, Lozzio CB, Lozzio BB. Induction of hemoglobin synthesis in original K562 cell line. Blood Cells. 1981;7:389–399
  43. Foster JS, Wust CJ, Lozzio CB, Bamberger EG, Ichiki AT. Natural killer cell resistance in K-562 cell sublines. Int. J. Cancer. 1985;35:343–349

PII: S0145-2126(00)00082-5

doi: 10.1016/S0145-2126(00)00082-5

Leukemia Research
Volume 24, Issue 12 , Pages 1049-1057 , December 2000

Article Tools

* Image Usage & Resolution